The dental membrane and bone graft substitute market comprises products such as allografts, xenografts, synthetic materials and growth factors used in dental surgeries to aid bone regeneration. Dental membranes act as barriers to prevent soft tissues from entering the bone defect site and helps guide regeneration. The bone graft substitutes serve as bone void fillers and osteoconductive scaffolds for bone formation. The demand for these products is rising owing to increasing prevalence of oral health issues such as periodontitis, periapical cysts and dental fractures caused by accidents or trauma. The Global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1,045.3 Mn in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the dental membrane and bone graft substitute market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DANAHER, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., and Medtronic. The rising need for various oral reconstructive surgeries and dental implants has fueled the demand for these products globally. Technological advancements such as development of resorbable membranes and 3D printed grafts have widened the applications of these biomaterials.
Market Trends
Increasing popularity of platelet rich plasma therapies - Platelet rich plasma (PRP) obtained from patient's own blood is being used along with dental membranes and bone grafts to enhance regeneration. PRP contains growth factors that aid soft and hard tissue healing.
Rise of tissue engineering approaches - Tissue engineered grafts incorporating cells, scaffolds and signaling molecules are being developed to mimic natural bone and enhance regeneration. These approaches could transform the market.
Market Opportunities
Untapped demand from developing economies - With rising income levels and awareness, many regions in Asia Pacific, Latin America, Middle East and Africa present lucrative opportunities.
Combination products - Integrating membranes, grafts and boosters in a single product could improve outcomes and compliance. Such combination strategies present new opportunities.
Impact of COVID-19 on Dental Membrane And Bone Graft Substitute Market Growth
The COVID-19 pandemic has adversely impacted the growth of the dental membrane and bone graft substitute market. During the initial stages of the pandemic in 2020, most dental procedures were postponed or canceled to curtail the spread of the virus. This led to limited utilization of bone graft substitutes and membrane products for various dental surgeries. The market witnessed a decline in demand as well as revenue during this period. However, as restrictions are being lifted now, the market is showing signs of recovery. With emphasis on preventive oral healthcare, the demand for bone grafting and regeneration procedures is expected to rise in the post-pandemic period. Market players are focusing on virtual consultations and digital technologies to engage with dentists and patients. They are ensuring adequate supplies and ramping up production to accommodate the expected rise in procedural volumes. New sanitization guidelines and personal protective equipment are being implemented across dental clinics to restore patient confidence and tackle the future waves of the pandemic effectively. The long term growth outlook for this market remains positive, driven by the rising elder population, growing dental tourism and increasing awareness about oral health.
In terms of value, North America holds the largest share in the dental membrane and bone graft substitute market owing to advanced dental healthcare infrastructure, high treatment costs and focus on cosmetic dentistry in the region. With nearly 60% share, the U.S. forms the major revenue pocket within North America. On the other hand, Asia Pacific region is projected to exhibit the highest CAGR during the forecast period due to rising disposable incomes, growing medical tourism and expanding dentist population in emerging countries like India and China. Latin America and Middle East & Africa also offer lucrative growth opportunities for players to tap the largely untapped potential.
